Skip to content

Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery

Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine Plus Dexamethasone for Mastectomy With Immediate Reconstruction

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03383198
Enrollment
5
Registered
2017-12-26
Start date
2017-12-01
Completion date
2019-08-30
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

This is a randomized controlled pilot study evaluating length of pain control with either liposomal bupivacaine or with bupivacaine plus decadron after PEC II injection in patients having bilateral mastectomies with immediate reconstruction.

Detailed description

This research hopes to determine the duration of patient-reported analgesia provided by ultrasound guided PEC II field block injections. The design of the study randomly assigns the side of injection of the study drugs into each patient. All patients are having bilateral mastectomy with immediate reconstruction. Visual analog pain scores (VAS) will be recorded serially for both sides of the patient's chest in hopes of determining a difference in duration and efficacy of the two drugs. In addition to VAS scores, a subjective, binary question will be our primary outcome: does one side of your chest have more surgical pain than the other? We hope that his question, despite being entirely subjective, overcomes interpatient variability of numerical pain score reporting.

Interventions

DRUGLiposomal bupivacaine right injection

Right side will have liposomal bupivacaine ultrasound guided PEC II field block injection ; the left side side will have bupivacaine plus dexamethasone ultrasound guided PEC II field block injection.

DRUGLiposomal bupivacaine left injection

Left side will have liposomal bupivacaine ultrasound guided PEC II field block injection ; the right side side will have bupivacaine plus dexamethasone ultrasound guided PEC II field block injection.

Sponsors

Prisma Health-Upstate
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Only anesthesiologist performing injection will be aware of which side is injected with each drug.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Scheduled for bilateral mastectomy

Exclusion criteria

* allergy to local anesthetics, prior breast surgery, asymmetric surgical plan

Design outcomes

Primary

MeasureTime frameDescription
Subjective Bilateral Pain Comparisonup to 48 hoursSubjective, binary question Does one side of your chest have more surgical pain than the other?

Secondary

MeasureTime frameDescription
Duration of Analgesiaup to 48 hoursDuration of analgesia perception by patient measured bilaterally using Visual Analog Scale

Countries

United States

Participant flow

Participants by arm

ArmCount
Liposomal Bupivacaine Left
Liposomal Bupivacaine left injection. Liposomal Bupivacaine is injected on the left, Bupivacaine plus Dexamethasone on the right Liposomal bupivacaine left injection: Left side will have liposomal bupivacaine ultrasound guided PEC II field block injection ; the right side side will have bupivacaine plus dexamethasone ultrasound guided PEC II field block injection.
4
Liposomal Bupivacaine Right
Liposomal Bupivacaine right injection. Liposomal Bupivacaine injected on the right, Bupivacaine plus Dexamethasone on the left Liposomal bupivacaine right injection: Right side will have liposomal bupivacaine ultrasound guided PEC II field block injection ; the left side side will have bupivacaine plus dexamethasone ultrasound guided PEC II field block injection.
1
Total5

Baseline characteristics

CharacteristicLiposomal Bupivacaine LeftLiposomal Bupivacaine RightTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
3 Participants1 Participants4 Participants
Age, Continuous59.25 years44 years56.2 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants1 Participants5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
4 Participants1 Participants5 Participants
Region of Enrollment
United States
4 participants1 participants5 participants
Sex: Female, Male
Female
4 Participants1 Participants5 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 5
other
Total, other adverse events
0 / 50 / 5
serious
Total, serious adverse events
0 / 50 / 5

Outcome results

Primary

Subjective Bilateral Pain Comparison

Subjective, binary question Does one side of your chest have more surgical pain than the other?

Time frame: up to 48 hours

Population: Patients undergoing bilateral mastectomy with immediate reconstruction by breast surgeons at Greenville Health System.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Liposomal Bupivacaine LeftSubjective Bilateral Pain Comparison1 Participants
Liposomal Bupivacaine RightSubjective Bilateral Pain Comparison0 Participants
Secondary

Duration of Analgesia

Duration of analgesia perception by patient measured bilaterally using Visual Analog Scale

Time frame: up to 48 hours

Population: Patients undergoing bilateral mastectomy with immediate reconstruction by breast surgeons at Greenville Health System.

ArmMeasureValue (MEAN)
Liposomal Bupivacaine LeftDuration of Analgesia21.5 hours
Liposomal Bupivacaine RightDuration of Analgesia36 hours

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026